126 related articles for article (PubMed ID: 16539846)
1. Liposome-mediated IL-28 and IL-29 expression in A549 cells and anti-viral effect of IL-28 and IL-29 on WISH cells.
Li MC; Wang HY; Wang HY; Li T; He SH
Acta Pharmacol Sin; 2006 Apr; 27(4):453-9. PubMed ID: 16539846
[TBL] [Abstract][Full Text] [Related]
2. Production, characterization, and applications of two novel monoclonal antibodies against human interleukin-28A.
Li M; Chen Y; Huang T; Liu Y; He S
Tissue Antigens; 2006 Dec; 68(6):477-82. PubMed ID: 17176437
[TBL] [Abstract][Full Text] [Related]
3. [Construction and expression of the eukaryotic expression vector containing AIF gene].
Deng WW; Liu SK; Zhang ZZ
Sichuan Da Xue Xue Bao Yi Xue Ban; 2013 Mar; 44(2):170-4. PubMed ID: 23745248
[TBL] [Abstract][Full Text] [Related]
4. Comparative analysis of the lambda-interferons IL-28A and IL-29 regarding their transcriptome and their antiviral properties against hepatitis C virus.
Diegelmann J; Beigel F; Zitzmann K; Kaul A; Göke B; Auernhammer CJ; Bartenschlager R; Diepolder HM; Brand S
PLoS One; 2010 Dec; 5(12):e15200. PubMed ID: 21170333
[TBL] [Abstract][Full Text] [Related]
5. Gene expression and antiviral activity of alpha/beta interferons and interleukin-29 in virus-infected human myeloid dendritic cells.
Osterlund P; Veckman V; Sirén J; Klucher KM; Hiscott J; Matikainen S; Julkunen I
J Virol; 2005 Aug; 79(15):9608-17. PubMed ID: 16014923
[TBL] [Abstract][Full Text] [Related]
6. Construction of eukaryotic expression vector of human CC10 gene and expression of CC10 protein in lung adenocarcinoma A549 cell line.
Zhong S; Xu Y; Zhang Z
J Huazhong Univ Sci Technolog Med Sci; 2005; 25(5):505-7. PubMed ID: 16463657
[TBL] [Abstract][Full Text] [Related]
7. Novel type I interferon IL-28A suppresses hepatitis C viral RNA replication.
Zhu H; Butera M; Nelson DR; Liu C
Virol J; 2005 Sep; 2():80. PubMed ID: 16146571
[TBL] [Abstract][Full Text] [Related]
8. Interleukin-29 uses a type 1 interferon-like program to promote antiviral responses in human hepatocytes.
Doyle SE; Schreckhise H; Khuu-Duong K; Henderson K; Rosler R; Storey H; Yao L; Liu H; Barahmand-pour F; Sivakumar P; Chan C; Birks C; Foster D; Clegg CH; Wietzke-Braun P; Mihm S; Klucher KM
Hepatology; 2006 Oct; 44(4):896-906. PubMed ID: 17006906
[TBL] [Abstract][Full Text] [Related]
9. [The effect of Na(+)/H(+) exchanger-1 (NHE-1) antisense expression vector on NHE-1 gene expression in human lung adenocarcinoma cells and its biological significance].
Wu GM; Qian GS; Huang GJ; Li SP; Yao W; Lu JY
Zhonghua Jie He He Hu Xi Za Zhi; 2004 Mar; 27(3):191-4. PubMed ID: 15130332
[TBL] [Abstract][Full Text] [Related]
10. Human blood dendritic cell antigen 3 (BDCA3)(+) dendritic cells are a potent producer of interferon-λ in response to hepatitis C virus.
Yoshio S; Kanto T; Kuroda S; Matsubara T; Higashitani K; Kakita N; Ishida H; Hiramatsu N; Nagano H; Sugiyama M; Murata K; Fukuhara T; Matsuura Y; Hayashi N; Mizokami M; Takehara T
Hepatology; 2013 May; 57(5):1705-15. PubMed ID: 23213063
[TBL] [Abstract][Full Text] [Related]
11. Biological activity of interleukins-28 and -29: comparison with type I interferons.
Meager A; Visvalingam K; Dilger P; Bryan D; Wadhwa M
Cytokine; 2005 Jul; 31(2):109-18. PubMed ID: 15899585
[TBL] [Abstract][Full Text] [Related]
12. Human type 2 myeloid dendritic cells produce interferon-λ and amplify interferon-α in response to hepatitis C virus infection.
Zhang S; Kodys K; Li K; Szabo G
Gastroenterology; 2013 Feb; 144(2):414-425.e7. PubMed ID: 23089201
[TBL] [Abstract][Full Text] [Related]
13. Interleukin 28A.rs12980602 and interleukin 28B.rs8103142 genotypes could be protective against HCV infection among Egyptians.
Zakaria ZA; Knapp S; Hashem M; Zaghla H; Thursz M; Waked I; Abdelwahab S
Immunol Res; 2019 Feb; 67(1):123-133. PubMed ID: 30402710
[TBL] [Abstract][Full Text] [Related]
14. [Effects of vesicular stomatitis virus matrix protein on proliferation and apoptosis of mouse LL/2c cells].
Zhao JM; Liu T; Xu JR; Wang GQ; Du XB; Wen YJ
Ai Zheng; 2007 Mar; 26(3):230-5. PubMed ID: 17355782
[TBL] [Abstract][Full Text] [Related]
15. Interferon-induced guanylate binding protein-1 (GBP-1) mediates an antiviral effect against vesicular stomatitis virus and encephalomyocarditis virus.
Anderson SL; Carton JM; Lou J; Xing L; Rubin BY
Virology; 1999 Mar; 256(1):8-14. PubMed ID: 10087221
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of vesicular stomatitis virus infection in epithelial cells by alpha interferon-induced soluble secreted proteins.
Basu M; Maitra RK; Xiang Y; Meng X; Banerjee AK; Bose S
J Gen Virol; 2006 Sep; 87(Pt 9):2653-2662. PubMed ID: 16894205
[TBL] [Abstract][Full Text] [Related]
17. [Construction and identification of human PRMT1 gene eukaryotic vector].
Li CY; Sun QZ; Yang XD; Zhong B; Han Y; Lv SM
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2012 Apr; 28(4):384-7. PubMed ID: 22482410
[TBL] [Abstract][Full Text] [Related]
18. IL-28A, IL-28B, and IL-29: promising cytokines with type I interferon-like properties.
Witte K; Witte E; Sabat R; Wolk K
Cytokine Growth Factor Rev; 2010 Aug; 21(4):237-51. PubMed ID: 20655797
[TBL] [Abstract][Full Text] [Related]
19. High-throughput profiling of alpha interferon- and interleukin-28B-regulated microRNAs and identification of let-7s with anti-hepatitis C virus activity by targeting IGF2BP1.
Cheng M; Si Y; Niu Y; Liu X; Li X; Zhao J; Jin Q; Yang W
J Virol; 2013 Sep; 87(17):9707-18. PubMed ID: 23824794
[TBL] [Abstract][Full Text] [Related]
20. Transcriptional regulation of IFN-λ genes in hepatitis C virus-infected hepatocytes via IRF-3·IRF-7·NF-κB complex.
Lee HC; Narayanan S; Park SJ; Seong SY; Hahn YS
J Biol Chem; 2014 Feb; 289(8):5310-9. PubMed ID: 24385435
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
